Bayer Overview

  • Founded
  • 1863
Founded
  • Status
  • Public
  • Employees
  • 99,439
Employees
  • Stock Symbol
  • BAYN
Stock Symbol
  • Investments
  • 63
  • Share Price
  • $56.35
  • (As of Wednesday Closing)

Bayer General Information

Description

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins. The company has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Contact Information

Website
www.bayer.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Agricultural Chemicals
Drug Discovery
Stock Exchange
ETR
Primary Office
  • Kaiser-Wilhelm-Allee 1
  • 51373 Leverkusen
  • Germany
+49 0214 000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bayer Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$56.35 $56.63 $46.61 - $69.72 $55.6B 982M 2.71M -$3.24

Bayer Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 99,420,293 91,131,991 122,154,053 108,261,901
Revenue 49,688,871 47,192,395 48,746,222 43,357,997
EBITDA (5,882,844) (13,300,504) 9,900,369 7,102,819
Net Income (3,197,120) (11,963,386) 4,579,648 2,000,212
Total Assets 136,172,365 143,962,707 141,336,589 144,873,027
Total Debt 48,044,174 51,108,815 43,554,530 47,350,721
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bayer Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bayer‘s full profile, request access.

Request a free trial

Bayer Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and
Pharmaceuticals
Leverkusen, Germany
99,439 As of 2021
00.00
000000000 00.00

0000000

sse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
0000 000000000
Ness Ziona, Israel
000 As of 0000
00000
000000000 00000

00000000

commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu f
0000 000000000
Gaithersburg, MD
0000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bayer Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Evogene Formerly VC-backed Ness Ziona, Israel 000 00000 000000000 00000
00000000 000000000 Corporation Gaithersburg, MD 0000 00000 000000000 00000
00000 Corporation Darmstadt, Germany 00000 00000000
000000 00000 Corporation Mumbai, India 0000
To view Bayer’s complete competitors history, request access »

Bayer Patents

Bayer Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3878741-A1 Unmanned aerial vehicle Pending 12-Mar-2020 0000000000
US-20210285859-A1 Filter membranes as antifoam level safeguards Pending 11-Mar-2020 000000000
EP-3878543-A1 Filter membranes as antifoam level safeguards Pending 11-Mar-2020 000000000
EP-3878542-A1 Filter membranes as antifoam level safeguards Pending 11-Mar-2020 000000000
EP-3875979-A1 Optimized procedure for dynamic contrast-enhanced magnetic resonance imaging Pending 06-Mar-2020 G01R33/5601

Bayer Executive Team (42)

Name Title Board Seat Contact Info
Sebastian Guth President, Bayer Pharmaceuticals Americas & Member of the Global Executive Committee
Johannes Dietsch Chief Financial Officer and Member of the Board of Management
Wolfgang Nickl Chief Financial Officer and Member of the Board of Management
Jeffrey Jarrett NA Chief Marketing Officer, Bayer Consumer Health
Hugo Pereira Director, Strategy Pharmaceuticals
You’re viewing 5 of 42 executive team members. Get the full list »

Bayer Board Members (26)

Name Representing Role Since
0000é 000 000000 Bayer Board Member 000 0000
0000000 0000000 Self Board Member 000 0000
000000 00000000 Bayer Board Member 000 0000
00000 0ö00000 Self Board Member 000 0000
00000 00000000 Bayer Board Member 000 0000
You’re viewing 5 of 26 board members. Get the full list »

Bayer Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bayer Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bayer‘s full profile, request access.

Request a free trial

Bayer Investments & Acquisitions (63)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 05-Aug-2021 000000000000000000 00.00 Drug Discovery
00000 000000000000 03-Jun-2021 000000000000000000 Drug Discovery 000000 000000
000 000000 30-May-2021 0000 00000 00000 Other Services (B2C Non-Financial)
0000000 01-Feb-2021 000000000000000000 00000 Other Pharmaceuticals and Biotechnology 000 000000
Senti Bio 06-Jan-2021 Later Stage VC 00000 Drug Discovery 0000 0000000 00
You’re viewing 5 of 63 investments and acquisitions. Get the full list »

Bayer Subsidiaries (15)

Company Name Industry Location Founded
BlueRock Therapeutics Drug Discovery Cambridge, MA 2016
0000000 Other Pharmaceuticals and Biotechnology New York, NY 0000
00000 00 00000 Corporate Venture Capital Leverkusen, Germany 0000
000 Accelerator/Incubator Berlin, Germany 0000
0000'0 0000000 000 Food Products Boulder, CO 0000
You’re viewing 5 of 15 subsidiaries. Get the full list »

Bayer Exits (17)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 02-Jul-2018 0000 00000 00.00 Completed
  • 11 buyers
000000'0 00000000 02-Oct-2014 000000000000000000 Completed
  • 00000
00000000 01-Jan-2008 00000 0000000 Completed
  • 2 buyers
0000000 0000000000 01-Jan-2008 00000 00000 00 0000 Completed
  • 4 buyers
Icon Genetics 11-Jan-2006 Merger/Acquisition 0000 Completed
You’re viewing 5 of 17 exits. Get the full list »